Cytori To Webcast Third Quarter Financial Results On November 8

Cytori Therapeutics (NASDAQ: CYTX) will provide a live webcast of its third quarter financial results and business update on Thursday, November 8, 2012 at 5:00 PM Eastern Time.

The dial-in information is as follows:
                Dial-In Number: +1.877.402.3914
Conference ID: 42763342

Prior to the webcast at approximately 4:05 PM Eastern Time on November 8, Cytori will issue its third quarter earnings release and post a quarterly shareholder letter to its Investor Relations homepage, which will review Cytori's third quarter performance.

The webcast will be available both live and by replay two hours after the call under “Webcasts” on the Company's Investor Relations website ( http://ir.cytori.com).

About Cytori

Cytori Therapeutics is developing cell therapies based on autologous adipose-derived regenerative cells (ADRCs) to treat cardiovascular disease and repair soft tissue defects. Our scientific data suggest ADRCs improve blood flow. As a result, we believe these cells can be applied across multiple “ischemic” conditions. These therapies are made available to the physician and patient at the point-of-care by Cytori’s proprietary technologies and products, including the Celution® System product family. www.cytori.com

Copyright Business Wire 2010

If you liked this article you might like

Biotech Movers: Red Hill Jumps After Securing Rights Sell GERD Treatment

Pharma Bro Martin Shkreli Awaits Jury Decision in Fraud Case

Cytori Therapeutics Stock Sliding on Offering Price Discount

GNC Plummets, Mallinckrodt Regains Ground Ahead of Market's Open

Insider Trading Alert - SUNE, NRIM And CYTX Traded By Insiders